Press Releases
 
Anti-arrhythmic Drugs Market - Current Trends and Future Aspect Analysis 2025

, 16 May 2018 -- Anti-arrhythmic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Cardiovascular diseases is one of the major causes of death across the globe. According to the World Health Organization, the number of deaths caused by these diseases is expected to reach over 23 million by 2030. These are largely lifestyle diseases and about 16% of deaths caused by these diseases in 2012 were attributed to high blood pressure. Various classes of drugs used to treat cardiac disorders include calcium channel blockers, anti-adrenergic agents, anti-arrhythmic agents, diuretic agents, and angiotensin-converting enzyme (ACE) inhibitors. Anti-arrhythmic drugs act by suppressing abnormal rhythm resulting from irregular electrical activity of the heart due to atrial flutter, and atrial and ventricular fibrillation.

Key anti-arrhythmic drugs include Pfizer’s Tikosyn (Dofetilide) and GlaxoSmithKline’s Rythmol (Propafenone). Sanofi’s Multaq (Dronedarone) was expected to be a prominent anti-arrhythmic drug. Sales of the drug suffered due to restrictions on prescriptions for permanent atrial fibrillation. Therapeutic innovations, increased disease awareness, and government intervention in curbing the number of deaths caused by cardiovascular diseases have helped reduce the mortality rate.

Statistics published by the American Health Association suggest that the mortality rate per 100,000 reduced from 342.9 in 2000 to 236.6 in 2010 in the U.S. The global anti-arrhythmic agents market was valued at US$ 561.0 Mn in 2013. Research and development in the field of drug discovery is projected to propel the global anti-arrhythmic drugs market during the forecast period. Moreover, increase in prevalence of various cardiovascular conditions is anticipated to drive demand for anti-arrhythmic drugs in the global market.

The global anti-arrhythmic drugs market can be segmented based on type, distribution channel, and region. In terms of type, the market can be classified into class I, class II, class III, and class IV. Class I anti-arrhythmic drugs consist of sodium (Na) channel blockers such as quinidine, disopyramide, procainamide, and lidocaine. Class II anti-arrhythmic drugs comprise beta blockers including propranolol, timolol, atenolol, and esmolol. Class III anti-arrhythmic drugs consists of potassium (K) channel blockers such as amiodarone, ibutilide, sotalol, and dofetilide. Class IV anti-arrhythmic drugs comprise calcium (Ca) channel blockers including verapamil and diltiazem. Few other drugs such as adenosine and digoxin having different mechanisms are included in the miscellaneous category of anti-arrhythmic drugs. Based on distribution channel, the global anti-arrhythmic drugs market can be segmented into hospital pharmacies, clinics, retail pharmacies, and online pharmacies.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35684

In terms of region, the global anti-arrhythmic drugs market can be segmented into North America, Europe, Asia Pacific, and Rest of the World. North America accounts for a major market share owing to extensive research and development activities, favorable reimbursement policies, and advanced health care infrastructure in the region. Implementation of the Affordable Care Act has imposed significant limitations on hospitals as well as pharmaceutical companies with respect to costing of new drugs.

Europe is the next major market for anti-arrhythmic drugs due to comprehensive intellectual property protection and presence of companies and organizations engaged in research. However, lack of proper reimbursement and regulatory framework pertaining to new drug development are key restraints of the market in Europe. Increase in prevalence of cardiovascular diseases in other regions of the world is likely to boost the anti-arrhythmic drugs market during the forecast period.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=35684

Key players operating in the global anti-arrhythmic drugs market are Pfizer, Inc., GlaxoSmithKline plc, Baxter International Inc., and Sandoz (a Novartis AG company), among others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email:
Website: http://www.transparencymarketresearch.com

# # #


Submitted by hawer on Wednesday, 16 May 2018 at 8:32 PM
Category: Health Care & Medical
 
Related News

Bleeding Disorder Treatment Market Trends Shows a Rapid Growth by 2025
Tuesday, 19 Mar 2019

Fibromyalgia Treatment Market Will Generate New Growth Opportunities By 2027
Tuesday, 19 Mar 2019

Cell Free Protein Expression Market Size, Status and Forecast to 2026
Monday, 18 Mar 2019

Heart Attack Diagnostics Market to Observe Significant Growth during 2016-2024
Monday, 18 Mar 2019

Single-Dose Therapy Market Growth Impact and Demand by Regions
Monday, 18 Mar 2019

Related Events

Principles of Pain Management and Palliative Care 2019
Sunday, 17 Mar 2019

The 29th International Pediatric Association (IPA) Congress 2019
Sunday, 17 Mar 2019

21st Annual Superbugs & Superdrugs Conference
Monday, 18 Mar 2019

2nd Adaptive Clinical Trials Symposium
Monday, 18 Mar 2019

SMi's 3rd Annual Drug Discovery Chemistry
Monday, 18 Mar 2019

Latest News

Bleeding Disorder Treatment Market Trends Shows a Rapid Growth by 2025
Tuesday, 19 Mar 2019

The Advantages of Getting a Virtual Phone Number for the Organization
Tuesday, 19 Mar 2019

Fibromyalgia Treatment Market Will Generate New Growth Opportunities By 2027
Tuesday, 19 Mar 2019

Cell Free Protein Expression Market Size, Status and Forecast to 2026
Monday, 18 Mar 2019

Heart Attack Diagnostics Market to Observe Significant Growth during 2016-2024
Monday, 18 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 19 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • COMEX - IT Telecom And Technology Show 2019
  • Principles of Pain Management and Palliative Care 2019
  • The 29th International Pediatric Association (IPA) Congress 2019
  • 21st Annual Superbugs & Superdrugs Conference
  • 2nd Adaptive Clinical Trials Symposium

  • Latest Jobs
    Sorry, there are currently no entries posted here.